Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma

Chest

Volumn 115, Issue 2, 1999, Pages 336-342

  Kemp, James P ^a,c   Minkwitz, Margaret C ^b   Bonuccelli, Catherine M ^b   Warren, Marshelle S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ASTRAZENECA   (United Kingdom)

^c ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

Author keywords

Asthma symptoms; Pulmonary function; Severe persistent asthma; Zafirlukast

Indexed keywords

LEUKOTRIENE; ZAFIRLUKAST;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SCHOOL CHILD; SLEEP PATTERN;

EID: 0032962751     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.2.336     Document Type: Article

References (9)

1. National Heart Lung, and Blood Institute. Executive summary: guidelines for the diagnosis and management of asthma. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1991. Publication No. 91-3042A
2. National Heart Lung, and Blood Institute. Executive summary: guidelines for the diagnosis and management of asthma. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1997. Publication No. 97-4051
3. Fish JE, Kemp JP, Lockey RF, et al. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. Clin Ther 1997; 19:675-690
4. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. N Engl J Med 1989; 317:426-432
5. Engel T, Dirksen A, Heinig JH, et al. Single-dose inhaled budesonide in subjects with chronic asthma. Allergy 1991; 46:547-553
6. Busse WW, Chervisnky P, Condemi J, et al. Budesonide delivered by Turbohaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998; 101:457-463
7. Pearlman DS, Noonan MJ, Tashkin DP, et al. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol 1997; 78:356-362
8. Ringdal N, Swinburn P, Backamn R, et al. A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation. Mediat Inflamm 1996; 5:382-389
9. Johansson SA, Dahl R. A double-blind dose response study of budesonide by inhalation in patients with bronchial asthma. Allergy 1987; 43:173-178